Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma

被引：0
|
作者：
Hajime Yasuda
Naoko Kaga
Hikari Taka
Tomonori Ochiai
Tomohito Yamana
Yoshiki Miura
Midori Ishii
Makoto Sasaki
Jun Ando
Miki Ando
机构：
[1] Juntendo University School of Medicine,Department of Hematology
[2] Juntendo University Graduate School of Medicine,Laboratory of Proteomics and Biomolecular Science, Biomedical Research Core Facilities
[3] Juntendo University School of Medicine,Department of Orthopedic Surgery
[4] Juntendo University School of Medicine,Department of Cell Therapy and Transfusion Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2024年 / 93卷 / 3期
关键词：
Pola-BR (polatuzumab vedotin; Bendamustine; Rituximab); MMAE (monomethyl auristatin E); Polivy; Renal replacement therapy; Brentuximab vedotin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 268
页数：3
相关论文
共 50 条
  • [1] Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma
    Yasuda, Hajime
    Kaga, Naoko
    Taka, Hikari
    Ochiai, Tomonori
    Yamana, Tomohito
    Miura, Yoshiki
    Ishii, Midori
    Sasaki, Makoto
    Ando, Jun
    Ando, Miki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (03) : 265 - 268
  • [2] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly, Herve
    Morschhauser, Franck
    Sehn, Laurie H.
    Friedberg, Jonathan W.
    Trneny, M.
    Sharman, Jeff P.
    Herbaux, Charles
    Burke, John M.
    Matasar, Matthew
    Rai, Shinya
    Izutsu, Koji
    Mehta-Shah, Neha
    Oberic, Lucie
    Chauchet, Adrien
    Jurczak, Wojciech
    Song, Yuqin
    Greil, Richard
    Mykhalska, Larysa
    Bergua-Burgues, Juan M.
    Cheung, Matthew C.
    Pinto, Antonio
    Shin, Ho-Jin
    Hapgood, Greg
    Munhoz, Eduardo
    Abrisqueta, Pau
    Gau, Jyh-Pyng
    Hirata, Jamie
    Jiang, Yanwen
    Yan, Mark
    Lee, Calvin
    Flowers, Christopher R.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
  • [3] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M.
    Zenz, T.
    Rosler, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 66 - 67
  • [4] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Herrera, Alex F.
    Flowers, Christopher R.
    Kamdar, Manali K.
    McMillan, Andrew
    Hertzberg, Mark
    Assouline, Sarit
    Kim, Tae Min
    Kim, Won Seog
    Ozcan, Muhit
    Hirata, Jamie
    Penuel, Elicia
    Paulson, Joseph N.
    Cheng, Ji
    Ku, Grace
    Matasar, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 155 - +
  • [5] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M. G.
    Zenz, T.
    Rosler, W.
    SWISS MEDICAL WEEKLY, 2020, : 21S - 21S
  • [6] An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma
    Walji, Moneeza
    Assouline, Sarit
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 933 - 942
  • [7] Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Shingleton, Jennifer R.
    Dave, Sandeep S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 166 - +
  • [8] Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
    Corcoran, Sean R.
    Phelan, James D.
    Choi, Jaewoo
    Shevchenko, Galina
    Fenner, Rachel E.
    Yu, Xin
    Scheich, Sebastian
    Hsiao, Tony
    Morris, Vivian M.
    Papachristou, Evangelia K.
    Kishore, Kamal
    D'Santos, Clive S.
    Ji, Yanlong
    Pittaluga, Stefania
    Wright, George W.
    Urlaub, Henning
    Pan, Kuan-Ting
    Oellerich, Thomas
    Muppidi, Jagan
    Hodson, Daniel J.
    Staudt, Louis M.
    CANCER DISCOVERY, 2024, 14 (09) : 1653 - 1674
  • [9] Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?
    Ghione, Paola
    Salles, Gilles
    HAEMATOLOGICA, 2024, 109 (09) : 2802 - 2809
  • [10] Therapeutic potential of polatuzumab vedotin for the treatment of diffuse large B-cell lymphoma
    Qi, Hui
    Wang, Fuyang
    Han, Bingrui
    Wang, Xiaomin
    Qiang, Xiangnan
    Zhang, Zhixiang
    Gu, Qiangyang
    CANCER RESEARCH, 2023, 83 (07)
12345